ABN Amro Investment Solutions Sells 6,760 Shares of Synopsys, Inc. $SNPS

ABN Amro Investment Solutions trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 5.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 110,956 shares of the semiconductor company’s stock after selling 6,760 shares during the period. ABN Amro Investment Solutions’ holdings in Synopsys were worth $43,992,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after acquiring an additional 283,677 shares in the last quarter. State Street Corp lifted its position in Synopsys by 0.3% during the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after acquiring an additional 28,532 shares during the last quarter. Morgan Stanley boosted its stake in Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock valued at $2,148,491,000 after acquiring an additional 109,917 shares in the last quarter. Geode Capital Management LLC grew its holdings in Synopsys by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock worth $2,017,256,000 after purchasing an additional 54,329 shares during the last quarter. Finally, Van ECK Associates Corp grew its holdings in Synopsys by 17.0% in the fourth quarter. Van ECK Associates Corp now owns 2,593,619 shares of the semiconductor company’s stock worth $1,218,275,000 after purchasing an additional 376,711 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SNPS. Bank of America increased their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Rosenblatt Securities upped their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. Wells Fargo & Company upped their target price on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Needham & Company LLC reissued a “buy” rating and issued a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Finally, KeyCorp restated an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $570.06.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Mizuho said Moonshot AI’s Kimi K3 release reinforces, rather than weakens, the case for agentic AI and could benefit EDA software leaders like Synopsys, prompting a “buy the dip” view after the recent selloff. Buy the dip in EDA stocks as Kimi K3 boosts agentic AI thesis: Mizuho
• Positive Sentiment: Another analysis argued Synopsys should benefit regardless of which companies win the AI race, since AI development across the industry still requires chip-design software and infrastructure. Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.
• Neutral Sentiment: Technical-trading coverage said SNPS was testing an important price level and had shown signs of stabilization, suggesting traders may be watching for a reversal rather than reacting to a new business catalyst. Stock Of The Day: Will Synopsys Reverse?
• Neutral Sentiment: Broader market headlines also mentioned SNPS in the context of a firmer futures market, which may have helped sentiment somewhat, but did not add company-specific news. Stock Market Today: S&P 500, Dow Jones Futures Gain as Trump Says Iran is ‘Very, Very Badly Damaged’— Eva Live, RTX, Synopsys in Focus

Synopsys Stock Up 2.8%

Synopsys stock opened at $389.07 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The business’s 50-day simple moving average is $464.07 and its two-hundred day simple moving average is $457.23. The company has a market cap of $74.50 billion, a PE ratio of 90.06, a PEG ratio of 2.22 and a beta of 1.22. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same period last year, the business posted $3.67 earnings per share. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.